Analyst Ratings on Definitive Healthcare
_____________________________________________________________________________________
Analysts have been sharing their views on Definitive Healthcare (NASDAQ:DH) in recent months, with opinions ranging from bullish to bearish. Here’s a summary of the latest analyst ratings and price targets:
Ratings Overview:
Total Ratings: 1 Bullish, 0 Somewhat Bullish, 3 Indifferent, 0 Somewhat Bearish, 0 Bearish.
Last 30 Days: 0 Bullish, 0 Somewhat Bullish, 1 Indifferent, 0 Somewhat Bearish, 0 Bearish.
1 Month Ago: 0 Bullish, 0 Somewhat Bullish, 1 Indifferent, 0 Somewhat Bearish, 0 Bearish.
Price Targets:
Average Target: $10.5
High Estimate: $11.00
Low Estimate: $10.00
Current Average Target Increase: 1.65% from the previous average of $10.33.
Key Analyst Actions and Insights:
Saket Kalia from Barclays upgraded the rating to Equal-Weight with a price target of $11.00. David Hayes from Canaccord Genuity changed the rating to Hold with a price target of $10.00. Conversely, David Grossman from Stifel downgraded the rating to Buy with a price target of $11.00.
Key Insights:
Analysts make adjustments to their recommendations based on market conditions and company performance.
The consensus rating score for Definitive Healthcare is currently at 2.50.
Analysts predict a potential upside of approximately 17.98% based on their forecasts.
For more in-depth information on analyst coverage and ratings for Definitive Healthcare, please visit the Definitive Healthcare Corp Investor Relations page.
DH Stock Shows Positive Momentum on March 1, 2024: Investors Encouraged by Price Increase
On March 1, 2024, DH stock showed positive price momentum as it traded in the middle of its 52-week range and above its 200-day simple moving average. The price of DH shares increased by $0.32 since the market last closed, representing a 3.48% rise. The stock closed at $9.52, showing a positive movement in the price. Despite the drop in pre-market trading, the overall performance of DH stock on March 1, 2024, was positive. Investors may have been encouraged by the price momentum and the increase in the stock price since the market last closed. It is important for investors to keep an eye on the market trends and news related to DH stock to make informed decisions about their investments.
DH Stock Analysis: Revenue Up, Net Income Down – Can Growth be Sustained?
On March 1, 2024, DH stock had a mixed performance based on the financial data provided by CNN Money. The total revenue for the company was reported at $251.41 million for the past year, representing a 12.92% increase compared to the previous year. However, the total revenue remained flat at $65.93 million for the last quarter.
The net income for DH was reported at -$202.39 million for the past year, showing a significant decrease of 2702.38% compared to the previous year. On the other hand, the net income improved slightly to -$10.23 million for the last quarter, with a 0.0% increase compared to the previous quarter.
Earnings per share (EPS) for DH stock were reported at -$1.79 for the past year, reflecting a decrease of 2413.73% compared to the previous year. The EPS improved slightly to -$0.09 for the last quarter, with a 0.0% increase compared to the previous quarter.
Overall, DH stock had a challenging year in terms of financial performance, with a significant decrease in net income and earnings per share. However, the company managed to increase its total revenue compared to the previous year. The flat performance in the last quarter indicates that the company may be facing some challenges in maintaining its growth momentum.
Investors and analysts will be closely monitoring DH stock in the coming months to see if the company can improve its financial performance and drive growth in the future. It will be important for DH to address the issues that led to the significant decrease in net income and earnings per share in order to regain investor confidence and drive stock performance.
